In January 2011, Kaiser Permanente named Elizabeth A. McGlynn, PhD, the former associate director of Rand Health, as director of the new Kaiser Permanente Center for Effectiveness and Safety Research. This new research center is a network of more than 400 researchers and clinicians, data managers, and analysts in Kaiser Permanente’s eight regional research centers experienced in effectiveness and safety research. CESR conducts in-depth studies of the safety and comparative effectiveness of drugs, devices, biologics, and care delivery strategies.
In 2011, CESR investigators participated in the U.S. Food and Drug Administration’s Mini-Sentinel pilot project, a forerunner of what will eventually be a nationwide rapid-response electronic safety surveillance system for drugs and other medical products. Our participation in this effort will lead to better understanding of the potential safety issues associated with FDA-approved medical products and enable scientists to gather responses to their questions far faster than by traditional surveillance methods.